Carlo Giaquinto-Cantarutti

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 313 publications

Pharmacokinetic modeling to support WHO-weight band dosing of a new pediatric darunavir/ritonavir (120/20 mg) fixed-dose combination tablet for children at least 3 years old and weighing 10 to less than 35 kg.

Pharmacokinetic modeling to support WHO-weight band dosing of a new pediatric darunavir/ritonavir (120/20 mg) fixed-dose combination tablet for children at least 3 years old and weighing 10 to less than 35 kg.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: August 21, 2026

Barriers and facilitators to adherence of infants living with HIV in sub-Saharan Africa in an era of wide access to ART: a mixed-methods study.

Barriers and facilitators to adherence of infants living with HIV in sub-Saharan Africa in an era of wide access to ART: a mixed-methods study.

Journal: AIDS and behavior

Published: July 10, 2026

Paediatric HIV cure section in Current Opinion in HIV and AIDS.

Paediatric HIV cure section in Current Opinion in HIV and AIDS.

Journal: Current opinion in HIV and AIDS

Published: June 04, 2026

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention.

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention.

Journal: JAMA network open

Published: May 19, 2026

RSV Detection and Antibiotic Prescribing Decisions for Pediatric Respiratory Tract Infections.

RSV Detection and Antibiotic Prescribing Decisions for Pediatric Respiratory Tract Infections.

Journal: JAMA network open

Published: March 03, 2026

Impaired Treg Response and Subclinical Cardiac Dysfunction in Children Following SARS-CoV-2 Infection.

Impaired Treg Response and Subclinical Cardiac Dysfunction in Children Following SARS-CoV-2 Infection.

Journal: The Pediatric infectious disease journal

Published: February 26, 2026

Pediatricians' attitudes and knowledge of RSV immunization products: A multi-country cross-sectional survey.

Pediatricians' attitudes and knowledge of RSV immunization products: A multi-country cross-sectional survey.

Journal: PloS one

Published: February 09, 2026

Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

Journal: Open forum infectious diseases

Published: January 26, 2026

Burden of non-invasive fungal infections and antifungal therapy in pediatric primary care settings: FUNGICARE Project.

Burden of non-invasive fungal infections and antifungal therapy in pediatric primary care settings: FUNGICARE Project.

Journal: Italian journal of pediatrics

Published: January 23, 2026

Phenotyping Pediatric Long COVID: Symptom Clusters from a Longitudinal Multicenter Italian Cohort.

Phenotyping Pediatric Long COVID: Symptom Clusters from a Longitudinal Multicenter Italian Cohort.

Journal: Children (Basel, Switzerland)

Published: January 09, 2026

Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis.

Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis.

Journal: JAMA network open

Published: January 08, 2026

SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistance.

SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistance.

Journal: BMC infectious diseases

Published: January 07, 2026

Showing 1-12 of 313

Last Updated: 09/26/2026